These interventions not only reduce proteinuria and preserve the GFR but also limit immune infiltration and fibrosis, supporting a pathophysiological role for the CaSR at the intersection of oxidative, immune, and tubular injury in hypertension-induced nephropathy. The gene discussed is CASR; the disease is Hypertension.